Citations

Citations to this article as recorded by  

• Anti-PD-1 antibody (Tislelizumab) combined with gemcitabine and oxaliplatin for extranodal NK/T-cell lymphoma failing asparaginase: A multicenter phase II trial
  Kaiyang Ding, Hailing Liu, Lixia Sheng, Jie Ma, Xiaohui Zhang, Hongming Huang, Wei Shi, Hongling Peng, Lei Cao, Wei Wu, Jianyong Li, Lei Fan
  European Journal of Cancer.2025; 214: 115155.     CrossRef
• MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
  Kyung Ju Ryu, Haein Ji, Bon Park, Sang Eun Yoon, Junhun Cho, Won Seog Kim, Hyeon Ho Kim, Seok Jin Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Tumor‐Associated Sympathetic Nerves Promote the Progression of Epstein‐Barr Virus‐Positive Diffuse Large B‐Cell Lymphoma
  Silan Huang, Dexin Lei, Linbin Yang, Aiwei Bi, Yanlou Wang, Peng Zhang, Dongyu Zhuang, Honglian Liu, Qingqing Cai, Man Nie, Yi Xia
  Advanced Science.2025;[Epub]     CrossRef
• Tislelizumab and Radiation Therapy in Low-Risk Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Phase II Study Protocol
  Jia-Ying Li, Shu-Nan Qi, Chen Hu, Xin Liu, Yong Yang, Tao Wu, Rong Zheng, Xiao-Li Feng, Xiao-Guang Ni, Feng-Yan Jin, Yu-Qin Song, Wei-Ping Liu, Sheng-Yu Zhou, Ye-Xiong Li
  Future Oncology.2024; 20(5): 245.     CrossRef
• Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review
  Mohammad Sadegh Fallahi, Nasibeh Zerangian, Atousa Ghorbani, Gisou Erabi, Melika Shirali, Elaheh Shabani, Foad Rommasi, Mahsa Mohammadi Najafabadi, Shima Karbasi, Samaneh Toutounchian, Ramin Ahangar-Sirous, Ava Motaghy, Mahsa Heidari, Niloofar Deravi
  Current Cancer Therapy Reviews.2024; 20(1): 53.     CrossRef
• The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for the management of post‐transplant lymphoproliferative disorders in children and adolescents
  Upton D. Allen, Arnaud G. L'Huillier, Catherine M. Bollard, Thomas G. Gross, Robert J. Hayashi, Britta Höcker, Britta Maecker‐Kolhoff, Stephen D. Marks, George Vincent Mazariegos, Francoise Smets, Ralf U. Trappe, Gary Visner, Richard E. Chinnock, Patrizia
  Pediatric Transplantation.2024;[Epub]     CrossRef
• Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
  Ji Yun Lee, Ji Hyun Kwon, Joon Young Hur, Jun Ho Yi, Ji Hyun Lee, Hyungwoo Cho, Young Rok Do, Jae-Cheol Jo, Hye Jin Kang, Yougil Koh, Won Sik Lee, Sung Nam Lim, Sang Eun Yoon, Seok Jin Kim, Jeong-Ok Lee
  Cancer Research and Treatment.2024; 56(2): 681.     CrossRef
• Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma
  Wendy W. L. Lee, Jing Quan Lim, Tiffany P. L. Tang, Daryl Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, Jackwee Lim, Kim Peng Tan, Wee Joo Chng, Soon Thye Lim, Choon Kiat Ong, Olaf Rotzschke
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art
  Magda Zanelli, Valentina Fragliasso, Paola Parente, Alessandra Bisagni, Francesca Sanguedolce, Maurizio Zizzo, Giuseppe Broggi, Stefano Ricci, Andrea Palicelli, Moira Foroni, Fabrizio Gozzi, Pietro Gentile, Andrea Morini, Nektarios Koufopoulos, Rosario Ca
  International Journal of Molecular Sciences.2024; 25(12): 6447.     CrossRef
• EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management
  Luis Malpica, Mario L. Marques‐Piubelli, Brady E. Beltran, Julio C. Chavez, Roberto N. Miranda, Jorge J. Castillo
  American Journal of Hematology.2024; 99(10): 2002.     CrossRef
• Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
  Maryam Pourmaleki, Caitlin J. Jones, Sabrina D. Mellinghoff, Brian D. Greenstein, Priyadarshini Kumar, Miguel Foronda, Daniel A. Navarrete, Carl Campos, Mikhail Roshal, Nikolaus Schultz, Sohrab P. Shah, Andrea Schietinger, Nicholas D. Socci, Travis J. Hol
  Clinical Cancer Research.2024; 30(17): 3881.     CrossRef
• PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis
  Youli Li, Yonghe Wu, Sufen Cao, Baohua Yu, Qunling Zhang, Zuguang Xia, Junning Cao, Fangfang Lv, Guang-Liang Chen
  Blood Research.2024;[Epub]     CrossRef
• The ‘Oma’s of the Gammas—Cancerogenesis by γ-Herpesviruses
  Anwesha Banerjee, Debashree Dass, Soumik Mukherjee, Mollina Kaul, R. Harshithkumar, Parikshit Bagchi, Anupam Mukherjee
  Viruses.2024; 16(12): 1928.     CrossRef
• A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
  Mwanasha H. Merrill, Parastoo B. Dahi, Robert A. Redd, Mikaela M. McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F. Herrera, David C. Fisher, Ann S. LaCasce, Oreofe O. Odejide, Samuel Y. Ng, Caron A. Jacobson, Reid W. Merryman, Austin I. Kim, Yago L. Ni
  Blood.2023; 142(7): 621.     CrossRef
• The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
  Yanxia He, Yan Gao, Liqin Ping, Haixia He, Cheng Huang, Bing Bai, Xiaoxiao Wang, Zhiming Li, Qingqing Cai, Yuhua Huang, Xueyi Pan, Wenbin Zeng, Yanan Liu, Huiqiang Huang
  Journal of Cancer Research and Clinical Oncology.2023; 149(5): 2017.     CrossRef
• Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
  Chunlan Zhang, Leiming Wang, Caigang Xu, Heng Xu, Yu Wu
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies
  Maria G. Desimio, Daniela A. Covino, Beatrice Rivalta, Caterina Cancrini, Margherita Doria
  Cancers.2023; 15(6): 1914.     CrossRef
• Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer
  Jie Zhou, Guanming Chen, Jiuling Wang, Bo Zhou, Xuemin Sun, Jinsong Wang, Shu Tang, Xiangju Xing, Xiaofei Hu, Yang Zhao, Yu Peng, Wenjiong Shi, Tingting Zhao, Yuzhang Wu, Hanbing Zhong, Ni Hong, Zhihua Ruan, Yi Zhang, Wenfei Jin
  Oncogenesis.2023;[Epub]     CrossRef
• Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
  Till Braun, Alexandra Schrader
  Cancers.2023; 15(9): 2532.     CrossRef
• Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review
  Sarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, Noémie Lang
  Biomedicines.2023; 11(6): 1720.     CrossRef
• First‐line immunotherapy with anti‐PD‐1 antibody for extranodal NK/T‐cell lymphoma: A retrospective study
  Xiaoxiao Wang, Lei Wen, Jing Liao, Yanfen Feng, Yuhong Li, Zhaoming Zhou, Cheng Zhou, Huiqiang Huang
  British Journal of Haematology.2023; 202(4): 812.     CrossRef
• Advances and challenges of immunotherapies in NK/T cell lymphomas
  Ling He, Na Chen, Lei Dai, Xingchen Peng
  iScience.2023; 26(11): 108192.     CrossRef
• Adult's Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis: A case report
  Yi Sun, Han Yao, Xiaofeng Yu, Yunzhao Chen, Chen Chai
  Clinical Case Reports.2023;[Epub]     CrossRef
• Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis
  Lingyue Xu, Xiaofang Guo, Hongzai Guan
  International Journal of Laboratory Hematology.2022; 44(1): 74.     CrossRef
• Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine
  Ka-Hei (Murphy) Sun, Yin-Ting (Heylie) Wong, Ka-Man (Carmen) Cheung, Carmen (Michelle) Yuen, Yun-Tat (Ted) Chan, Wing-Yan (Jennifer) Lai, Chun (David) Chao, Wing-Sum (Katie) Fan, Yuen-Kiu (Karen) Chow, Man-Fai Law, Ho-Chi (Tommy) Tam
  Diagnostics.2022; 12(2): 409.     CrossRef
• The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
  Alison Felipe Bordini Biggi, Deilson Elgui de Oliveira
  Biomolecules.2022; 12(3): 397.     CrossRef
• Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
  Xi Chen, Wanchun Wu, Wenwen Wei, Liqun Zou
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management
  Luis Malpica, Mario L. Marques‐Piubelli, Brady E. Beltran, Julio C. Chavez, Roberto N. Miranda, Jorge J. Castillo
  American Journal of Hematology.2022; 97(7): 951.     CrossRef
• Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions
  John C. Reneau, Polina Shindiapina, Zachary Braunstein, Youssef Youssef, Miguel Ruiz, Saira Farid, Walter Hanel, Jonathan E. Brammer
  Journal of Clinical Medicine.2022; 11(10): 2699.     CrossRef
• Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
  Susan Swee-Shan Hue, Siok-Bian Ng, Shi Wang, Soo-Yong Tan
  Cancers.2022; 14(10): 2483.     CrossRef
• Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
  Yang Xu, Ping Li, Yang Liu, Dijia Xin, Wen Lei, Aibin Liang, Weidong Han, Wenbin Qian
  Cancer Communications.2022; 42(6): 493.     CrossRef
• Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression
  N Nora Bennani, Hyo Jin Kim, Levi D Pederson, Pamela J Atherton, Ivana N Micallef, Gita Thanarajasingam, Grzegorz S Nowakowski, Thomas Witzig, Andrew L Feldman, Stephen M Ansell
  Journal for ImmunoTherapy of Cancer.2022; 10(6): e004984.     CrossRef
• Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma
  Felix Marsh-Wakefield, Angela L Ferguson, Ken Liu, Cositha Santhakumar, Geoffrey McCaughan, Umaimainthan Palendira
  Therapeutic Advances in Medical Oncology.2022;[Epub]     CrossRef
• Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
  Eric Tse, Christopher P. Fox, Alexander Glover, Sang Eun Yoon, Won Seog Kim, Yok-Lam Kwong
  Seminars in Hematology.2022; 59(4): 198.     CrossRef
• Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
  Seok Jin Kim, Kyung Ju Ryu, Bon Park, Sang Eun Yoon, Junhun Cho, Yoon Park, Won Seog Kim
  Cancers.2022; 14(22): 5618.     CrossRef
• Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma
  Guang-Liang Chen, Zu-Guang Xia, Jia Jin, Bao-Hua Yu, Junning Cao, Amir Radfar
  Journal of Oncology.2021; 2021: 1.     CrossRef
• Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review
  Lee S. Nguyen, Lisa Raia, Bénédicte Lebrun-Vignes, Joe-Elie Salem
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Pulmonary Lymphoepithelioma-Like Carcinoma Treated with Immunotherapy or Chemotherapy: A Single Institute Experience
  Yang Fu, Yue Zheng, Pei-Pei Wang, Yue-Yun Chen, Zhen-Yu Ding
  OncoTargets and Therapy.2021; Volume 14: 1073.     CrossRef
• EBV et immunodépression
  Y. Dieudonne, M. Martin, A.-S. Korganow, D. Boutboul, A. Guffroy
  La Revue de Médecine Interne.2021; 42(12): 832.     CrossRef
• PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
  Joshua W. D. Tobin, Karolina Bednarska, Ashlea Campbell, Colm Keane
  Cells.2021; 10(5): 1152.     CrossRef
• NK-/T-cell lymphomas
  Hua Wang, Bi-bo Fu, Robert Peter Gale, Yang Liang
  Leukemia.2021; 35(9): 2460.     CrossRef
• The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment
  Emad Ababneh, Anas M Saad, Genevieve M Crane
  Histopathology.2021; 79(4): 451.     CrossRef
• Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
  Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, Sang Eun Yoon, Kirit M. Ardeshna, Yi Lin, Jia Ruan, Pierluigi Porcu, Jonathan E. Brammer, Eric D. Jacobsen, Dok Hyun Yoon, Cheolwon Suh, Felipe Suarez, John Radford, Lihua E. Budde, Jin Seok Kim, Emmanuel Bachy, H
  Annals of Hematology.2021; 100(10): 2529.     CrossRef
• The Role of Epstein–Barr virus-encoded Latent Membrane Proteins in Host Immune Escape
  Yuanyuan Jiang, Yuan Ding, Shuzhen Liu, Bing Luo
  Future Virology.2021; 16(8): 565.     CrossRef
• EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)
  Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Luca Valle, Stefano Ricci, Alberto Cavazza, Francesco Merli, Stefano A. Pileri, Stefano Ascani
  Cancers.2021; 13(18): 4578.     CrossRef
• Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report
  Fatemeh Adabifirouzjaei, Bharam Khazai, Ghazaleh Azami, Ghazaleh Shoja-e-Razavi
  Journal of Medical Case Reports.2021;[Epub]     CrossRef
• Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
  Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez, Jose-Tomas Navarro
  Cancers.2021; 13(21): 5534.     CrossRef
• Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus
  Leila Sawada, Antonio Carlos Rosário Vallinoto, Igor Brasil-Costa
  Biomolecules.2021; 11(12): 1792.     CrossRef
• Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
  Alejandro Olivares-Hernández, Luis Figuero-Pérez, José Pablo Miramontes-González, Álvaro López-Gutiérrez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Emilio Fonseca-Sánchez
  Life.2021; 11(12): 1400.     CrossRef
• EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk‐stratification and management
  Brady E. Beltran, Denisse Castro, Sally Paredes, Roberto N. Miranda, Jorge J. Castillo
  American Journal of Hematology.2020; 95(4): 435.     CrossRef
• Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
  Junhun Cho, Seok Jin Kim, Woong-Yang Park, Jinho Kim, Jeongmin Woo, Gahyun Kim, Sang Eun Yoon, Young Hyeh Ko, Won Seog Kim
  Modern Pathology.2020; 33(4): 603.     CrossRef
• PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
  Matthew J. Frigault, Philippe Armand, Robert A. Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jenni
  Blood Advances.2020; 4(1): 122.     CrossRef
• Checkmate for EBV-HLH
  Nader Kim El-Mallawany, Kenneth L. McClain
  Blood.2020; 135(11): 782.     CrossRef
• CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
  Yue Song, Wei Song, Zhaoming Li, Wenting Song, Yibo Wen, Jiwei Li, Qingxin Xia, Mingzhi Zhang
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Stage IV natural killer/T-cell lymphoma with chronic active Epstein–Barr virus, treated with pembrolizumab and TCRαβ-depleted haploidentical hematopoietic stem cell transplantation
  Yeong Eun Kim, Hyery Kim, Juhee Shin, So Yoon Min, Sung Han Kang, Jin Kyung Suh, Kyung-Nam Koh, Ho Joon Im
  Leukemia & Lymphoma.2020; 61(9): 2250.     CrossRef
• Virus-Specific T Cells for the Treatment of Malignancies—Then, Now, and the Future
  Sandhya Sharma, Wingchi K Leung, Helen E Heslop
  Current Stem Cell Reports.2020; 6(2): 17.     CrossRef
• The roles of programmed death ligand 1 in virus-associated cancers
  Morvarid Golrokh Mofrad, Donya Taghizadeh Maleki, Ebrahim Faghihloo
  Infection, Genetics and Evolution.2020; 84: 104368.     CrossRef
• Immune-Checkpoint Blockade Therapy in Lymphoma
  Ayumi Kuzume, SungGi Chi, Nobuhiko Yamauchi, Yosuke Minami
  International Journal of Molecular Sciences.2020; 21(15): 5456.     CrossRef
• Multiplex immunohistochemistry in lymphoma pathology: a research tool for study of the immune microenvironment
  Matthew Pugh, Ayse U. Akarka, Kelly Hunter, Stefan Dojcinov, Teresa Marafioti
  Diagnostic Histopathology.2020; 26(9): 407.     CrossRef
• Targeting immune checkpoints in hematological malignancies
  Basit Salik, Mark J. Smyth, Kyohei Nakamura
  Journal of Hematology & Oncology.2020;[Epub]     CrossRef
• Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas
  Yonggang Pei, Josiah H. Y. Wong, Erle S. Robertson
  Cancers.2020; 12(9): 2565.     CrossRef
• Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
  Polina Shindiapina, Elshafa H. Ahmed, Anna Mozhenkova, Tamrat Abebe, Robert A. Baiocchi
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
  Ji-Yoon Noh, Huiyun Seo, Jungwoon Lee, Haiyoung Jung
  International Journal of Molecular Sciences.2020; 21(21): 8000.     CrossRef
• EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas
  Danielle L.V. Maracaja, Vidya Puthenpura, Salley G. Pels, Dennis P. O’Malley, Jeffrey L. Sklar, Karin E. Finberg, Mina L. Xu
  Applied Immunohistochemistry & Molecular Morphology.2020; 28(10): 725.     CrossRef
• Current Immunotherapy Approaches in Non-Hodgkin Lymphomas
  Robert Pytlik, Kamila Polgarova, Jana Karolova, Pavel Klener
  Vaccines.2020; 8(4): 708.     CrossRef
• Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review
  Zheng Yan, Shuna Yao, Yanyan Liu, Jianbo Zhang, Peng Li, Haiying Wang, Junfeng Chu, Shuang Zhao, Zhihua Yao
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study
  Seok Jin Kim, Jing Quan Lim, Yurike Laurensia, Junhun Cho, Sang Eun Yoon, Ji Young Lee, Kyung Ju Ryu, Young Hyeh Ko, Youngil Koh, Duck Cho, Soon Thye Lim, Marie Beck Enemark, Francesco D’Amore, Mette Bjerre, Choon Kiat Ong, Won Seog Kim
  Blood.2020; 136(24): 2754.     CrossRef
• Pembrolizumab
  
  Reactions Weekly.2019; 1754(1): 273.     CrossRef
• Immune checkpoint inhibitors in the treatment of virus-associated cancers
  Peipei Gao, Cordelle Lazare, Canhui Cao, Yifan Meng, Ping Wu, Wenhua Zhi, Shitong Lin, Juncheng Wei, Xiaoyuan Huang, Ling Xi, Gang Chen, Junbo Hu, Ding Ma, Peng Wu
  Journal of Hematology & Oncology.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• The Value of Ultrasound and Contrast‐Enhanced Ultrasound in a Young Asymptomatic Patient With Duodenal Neuroendocrine Neoplasms: A Case Report
  Huiyu Yang, Lin Zhao, Xiang Jing, Yanmin Kan
  Journal of Clinical Ultrasound.2025; 53(5): 1176.     CrossRef
• Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database
  Abuduhaibaier Sadula, Gang Li, Dianrong Xiu, Chen Ye, Siqian Ren, Xin Guo, Chunhui Yuan, Min Tang
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors
  Xiaoxiao Jiao, Wenqing Luan, Xiaoqian Peng, Lu Liu, Lianfeng Zhang, Lin Zhou
  Medicine.2020; 99(51): e23655.     CrossRef
• Analysis of B-ultrasound and contrast-enhanced ultrasound characteristics of different hepatic neuroendocrine neoplasm
  Xiao-Ning Kang, Xiao-Yu Zhang, Jie Bai, Zun-Yi Wang, Wen-Jie Yin, Li Li
  World Journal of Gastrointestinal Oncology.2019; 11(5): 436.     CrossRef
• Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
  Lingaku Lee, Tetsuhide Ito, Robert T Jensen
  Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
• A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component
  Quang Duy Pham, Ichiro Mori, Robert Y. Osamura
  Case Reports in Pathology.2017; 2017: 1.     CrossRef
• Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
  Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Ko Watanabe, Jun Nakamura, Hitomi Kikuchi, Yuichi Waragai, Mika Takasumi, Satoshi Kawana, Yuko Hashimoto, Takuto Hikichi, Hiromasa Ohira
  World Journal of Clinical Oncology.2017; 8(3): 293.     CrossRef
• Gastroenteropancreatic—origin neuroendocrine carcinomas
  Yong Gyun Won, Kyung-Jin Seo, Jiyeon Hyeon, Ok Ran Shin, Eundeok Chang, Der Sheng Sun, Hae Sung Won, Yoon Ho Ko, Sae Jung Na, Su Lim Lee, Young Mi Ku, Dong Soo Lee
  Medicine.2017; 96(49): e9009.     CrossRef
• A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases
  Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen
  International Journal of Surgery.2016; 29: 108.     CrossRef
• Liver Metastasis of Gastrointestinal Neuroendocrine Tumors: A Single Center Experience
  Bita Geramizadeh, Ali Kashkooe, Seyed Ali Malekhosseini
  Hepatitis Monthly.2016;[Epub]     CrossRef
• Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification
  Deepak Kalyansingh Burad, Thomas Alex Kodiatte, Sayd Mohamed Rajeeb, Ashish Goel, Chundamannil Eapen Eapen, Banumathi Ramakrishna
  World Journal of Gastroenterology.2016; 22(40): 8956.     CrossRef
• Unusual endoscopic findings of gastric neuroendocrine tumor
  Kazuhiro Kishi, Akihiko Fujisawa, Minoru Horikita, Yoshihiro Nakai, Kazushi Ooshimo, Fumiko Kishi, Masako Kimura, Chun-che Lin, Tetsuji Takayama
  The Journal of Medical Investigation.2015; 62(3.4): 251.     CrossRef